Indeed, Notch1 levels inversely correlated with the expression of E-cadherin in paclitaxel-resistant prostatic cancer, and GSI-mediated inactivation of Notch1 and Notch4 reversed the sensitivity of cancer cells to this taxane. The gene discussed is NOTCH1; the disease is prostate carcinoma.